1. Market Research
  2. > ViroPharma Incorporated - Product Pipeline Review - 2013

ViroPharma Incorporated - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 38 pages

ViroPharma Incorporated - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “ViroPharma Incorporated - Product Pipeline Review - 2013” provides data on the ViroPharma Incorporated’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ViroPharma Incorporated’s corporate website, SEC filings, investor presentations and featured press releases, both from ViroPharma Incorporated and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- ViroPharma Incorporated - Brief ViroPharma Incorporated overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of ViroPharma Incorporated human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of ViroPharma Incorporated with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the ViroPharma Incorporated’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate ViroPharma Incorporated’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of ViroPharma Incorporated in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the ViroPharma Incorporated’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with ViroPharma Incorporated.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of ViroPharma Incorporated and identify potential opportunities in those areas.

Table Of Contents

ViroPharma Incorporated - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
ViroPharma Incorporated Snapshot 5
ViroPharma Incorporated Overview 5
Key Information 5
Key Facts 5
ViroPharma Incorporated - Research and Development Overview 6
Key Therapeutic Areas 6
ViroPharma Incorporated - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
ViroPharma Incorporated - Pipeline Products Glance 10
ViroPharma Incorporated - Late Stage Pipeline 10
Phase III Products/Combination Treatment Modalities 10
ViroPharma Incorporated Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
ViroPharma Incorporated - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
ViroPharma Incorporated - Drug Profiles 14
conestat alfa 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
hydrocortisone acetate 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
maribavir 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
VP-20621 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
VP-20629 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
ViroPharma Incorporated - Pipeline Analysis 19
ViroPharma Incorporated - Pipeline Products by Therapeutic Class 19
ViroPharma Incorporated - Pipeline Products By Target 21
ViroPharma Incorporated - Pipeline Products by Route of Administration 22
ViroPharma Incorporated - Pipeline Products By Mechanism of Action 23
ViroPharma Incorporated - Recent Pipeline Updates 24
ViroPharma Incorporated - Dormant Projects 30
ViroPharma Incorporated - Discontinued Pipeline Products 31
Discontinued Pipeline Product Profiles 31
HCV-796 31
maribavir 31
ViroPharma Incorporated - Company Statement 32
ViroPharma Incorporated - Locations And Subsidiaries 35
Head Office 35
Other Locations and Subsidiaries 35
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 38
Disclaimer 38

List of Tables

ViroPharma Incorporated, Key Information 5
ViroPharma Incorporated, Key Facts 5
ViroPharma Incorporated - Pipeline by Indication, 2013 7
ViroPharma Incorporated - Pipeline by Stage of Development, 2013 8
ViroPharma Incorporated - Monotherapy Products in Pipeline, 2013 9
ViroPharma Incorporated - Phase III, 2013 10
ViroPharma Incorporated - Phase II, 2013 11
ViroPharma Incorporated - Phase I, 2013 12
ViroPharma Incorporated - Preclinical, 2013 13
ViroPharma Incorporated - Pipeline By Therapeutic Class, 2013 20
ViroPharma Incorporated - Pipeline By Target, 2013 21
ViroPharma Incorporated - Pipeline By Route of Administration, 2013 22
ViroPharma Incorporated - Pipeline Products By Mechanism of Action, 2013 23
ViroPharma Incorporated - Recent Pipeline Updates, 2013 24
ViroPharma Incorporated - Dormant Developmental Projects,2013 30
ViroPharma Incorporated - Discontinued Pipeline Products, 2013 31
ViroPharma Incorporated, Subsidiaries 35

List of Figures

ViroPharma Incorporated - Pipeline by Indication, 2013 7
ViroPharma Incorporated - Pipeline by Stage of Development, 2013 8
ViroPharma Incorporated - Monotherapy Products in Pipeline, 2013 9
ViroPharma Incorporated - Pipeline By Therapeutic Class, 2013 19
ViroPharma Incorporated - Pipeline By Route of Administration, 2013 22
ViroPharma Incorporated - Pipeline Products By Mechanism of Action, 2013 23

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.